# Zhejiang Better Pharmaceuticals Co., Ltd. – FDA Inspection, Sep 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-better-pharmaceuticals-co-ltd/fcb73a00-e926-4ccd-8bc6-4e6040b5a9e6
Source feed: FDA_Inspections

> FDA inspection 1252973 of Zhejiang Better Pharmaceuticals Co., Ltd., September 26, 2024. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252973
- Company Name: Zhejiang Better Pharmaceuticals Co., Ltd.
- Inspection Date: 2024-09-26
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1005236 - 2017-01-20](https://www.keypedia.com/records/fda_inspections/zhejiang-better-pharmaceuticals-co-ltd/7f3f48bd-c3a3-4dcb-8a6c-b354f1364c91)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/matthew-m-schuckmann/69dd0728-6b5d-41e7-834c-416e25a977dc)

Company: https://www.keypedia.com/companies/zhejiang-better-pharmaceuticals-co-ltd/487aea91-5bd2-4eaf-ac4e-899ede833b28

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c